EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of tumor microbiome with survival in resected early-stage PDAC

Yixuan Meng iD, Chan Wang, Mykhaylo Usyk iD, Soyoung Kwak iD, Chengwei Peng, Kenneth S Hu, Paul E Oberstein iD, Michelle Krogsgaard, Huilin Li iD, Richard B Hayes iD, Jiyoung Ahn iD

mSystems · 2025

DOI: 10.1128/msystems.01229-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Yixuan Meng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NLM NIH HHS, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pancreas tumor microbiota may influence tumor microenvironment and influence survival in early-stage pancreatic ductal adenocarcinoma (PDAC); however, current studies are limited and small. We investigated the relationship of tumor microbiota to survival in 201 surgically resected patients with localized PDAC (Stages I–II), from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) cohorts. We characterized the tumor microbiome using RNA-sequencing data. We examined the association of the tumor microbiome with overall survival (OS), via meta-analysis with the Cox PH model. A microbial risk score (MRS) was calculated from the OS-associated microbiota. We further explored whether the OS-associated microbiota is related to host tumor immune infiltration. PDAC tumor microbiome α- and β-diversities were not associated with OS; however, 11 bacterial species, including species of Gammaproteobacteria , confirmed by extensive resampling, were significantly associated with OS (all Q < 0.05). The MRS summarizing these bacteria was related to a threefold change in OS (hazard ratio = 2.96 per standard deviation change in the MRS, 95% confidence interval = 2.26–3.86). This result was consistent across the two cohorts and in stratified analyses by adjuvant therapy (chemotherapy/radiation). Identified microbiota and the MRS also exhibited association with memory B cells and naïve CD4 + T cells, which may be related to the immune landscape through BCR and TCR signaling pathways. Our study shows that a unique tumor microbiome structure, potentially affecting the tumor immune microenvironment, is associated with poorer survival in resected early-stage PDAC. These findings suggest that microbial mechanisms may be involved in PDAC survival, potentially informing PDAC prognosis and guiding personalized treatment strategies. IMPORTANCE Much of the available data on the PDAC tumor microbiome and survival are derived from relatively small and heterogeneous studies, including those involving patients with advanced stages of pancreatic cancer. There is a critical knowledge gap in terms of the tumor microbiome and survival in early-stage patients treated by surgical resection; we expect that advancements in survival may initially be best achieved in these patients who are treated with curative intent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsMicrobiotaHumansFemaleMaleTumor MicroenvironmentMiddle AgedAgedNeoplasm Staging

Stichwörter der Autor:innen

early stagepancreatic cancersurvivaltumor tissue microbiome

Autor:innen und Institutionen

  • Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA.
  • NYU Laura and Isaac Perlmutter Cancer Center, New York, New York, USA.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Pathology, NYU Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Yixuan Meng, Mykhaylo Usyk, Soyoung Kwak, Paul E Oberstein, Huilin Li, Richard B Hayes, Jiyoung Ahn

Förderung

  • NCI NIH HHS
  • NLM NIH HHS
  • HHS | NIH | National Cancer Institute
  • HHS | NIH | U.S. National Library of Medicine

Zitieren

APA

Meng, Y., Wang, C., Usyk, M., Kwak, S., Peng, C., Hu, K. S., Oberstein, P. E., Krogsgaard, M., Li, H., Hayes, R. B., & Ahn, J. (2025). Association of tumor microbiome with survival in resected early-stage PDAC. mSystems. https://doi.org/10.1128/msystems.01229-24

Vancouver

Meng Y, Wang C, Usyk M, Kwak S, Peng C, Hu KS, et al. Association of tumor microbiome with survival in resected early-stage PDAC. mSystems. 2025. doi:10.1128/msystems.01229-24

BibTeX
@article{Meng2025,
  author = {Meng, Yixuan and Wang, Chan and Usyk, Mykhaylo and Kwak, Soyoung and Peng, Chengwei and Hu, Kenneth S and Oberstein, Paul E and Krogsgaard, Michelle and Li, Huilin and Hayes, Richard B and Ahn, Jiyoung},
  title = {Association of tumor microbiome with survival in resected early-stage PDAC},
  journal = {mSystems},
  year = {2025},
  doi = {10.1128/msystems.01229-24}
}
Kostenlos starten →